Asymbekova E U, Bunin Iu A, Pomerantsev E V, Firstova M I, Bakashvili N G
Kardiologiia. 1987 Apr;27(4):68-71.
The effect of Ritmilen and allapinin, a new Soviet antiarrhythmic drug, on hemodynamics and myocardial contractility were evaluated in 36 patients with various heart rhythm disorders during diagnostic coronary angiography. Ritmilen has been shown to have an essential cardiodepressive effect. An intravenous 150 mg dose of Ritmilen results in a depression of dp/dtmax, Veragut's index, ejection fraction, mean standard circular fibre shortening rate, and increase in left ventricular systolic and end diastolic pressure, total peripheral resistance and mean arterial blood pressure. Allapinin (30 mg) has no marked cardiodepressive effect, as compared to Ritmilen.
在36例患有各种心律失常的患者进行诊断性冠状动脉造影期间,评估了苏联一种新型抗心律失常药物利米特林(Ritmilen)和阿拉平宁(allapinin)对血流动力学和心肌收缩力的影响。已证明利米特林具有显著的心脏抑制作用。静脉注射150毫克利米特林会导致dp/dtmax、韦拉古特指数(Veragut's index)、射血分数、平均标准环形纤维缩短率降低,并使左心室收缩压和舒张末期压力、总外周阻力和平均动脉血压升高。与利米特林相比,阿拉平宁(30毫克)没有明显的心脏抑制作用。